Hodgkin’s lymphoma and non-Hodgkin’s lymphoma can occur in children, adolescents, and adults. However, non-Hodgkin’s lymphoma becomes more common with age. Unlike most cancers, rates of Hodgkin’s lymphoma are highest among teenagers and young adults (15 to 39 years old) and older people (75 years old and older).
The disease was first described in 1832 by an English scientist, Sir Thomas Hodgkin. This is where lymphoma gets its name. Lymphogranulomatosis (the second name of this disease) is a malignant neoplasm, in which giant tumor elements are found in the lymph nodes – Berezovsky-Sternberg-Reed cells. More often, the cervical or supraclavicular lymph nodes become the source.
Given the long history of the disease, the world’s leading scientists are focused on fighting this type of cancer. Israeli oncologists have long been part of a large coalition of specialists who test new methods of lymphoma therapy for patients of different ages. For the treatment of lymphoma in Israel for the period of 2023, more than 200 clinical trials of new anti-cancer drugs are being conducted.